Dr. Koyner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5841 S. MARYLAND
M/C 5100
Chicago, IL 60637Phone+1 773-702-3630Fax+1 773-753-8301- Is this information wrong?
Summary
- Jay L. Koyner, MD, is a Professor of Medicine in the Section of Nephrology at the University of Chicago. Dr. Koyner completed his internal medicine and nephrology training at the University of Chicago, where he currently serves as the medical director of the Inpatient Dialysis Unit and Director of ICU Nephrology. In addition to being a dedicated clinician educator, his critical care nephrology research interests have focused on the utilization of plasma and urine biomarkers to improve patient risk stratification and outcomes in the setting of AKI. He has been awarded several NIH and Industry-sponsored grants. He has contributed to several multicenter centers investigating the biomarkers of AKI. More recently he has begun developing and implementing an electronic health record derived AKI risk score with the hopes of improving the care of patients at high risk for the development of severe hospital-acquired AKI. He has published over 150 peer-reviewed articles and book chapters on AKI.
Additionally, he has served several educational roles institutionally, nationally, and internationally. He has served as a core-faculty member for the University of Chicago Internal Medicine Residency and Nephrology Fellowship. Over the last decade, he has held many roles in the American Society of Nephrology including but not limited to being a member of the Acute Kidney Injury Advisory Group, co-director of the Critical Care Nephrology pre-course (2014 to 2018), co-editor of the Nephrology Self-Assessment Program (NephSAP) for Acute Kidney Injury and Critical Care Nephrology (2016 to 2019). He has served on the editorial review board of the Clinical Journal of the American Society of Nephrology, Kidney360, The American Journal of Nephrology, and Advances in Chronic Kidney Disease.
Education & Training
University of ChicagoFellowship, Nephrology, 2004 - 2006- University of ChicagoResidency, Internal Medicine, 2001 - 2004
Stony Brook University Health Sciences Center School of MedicineClass of 2001
The Johns Hopkins UniversityBA, Biophysics, 1992 - 1996
Certifications & Licensure
IL State Medical License 2001 - 2026
IN State Medical License 2023 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Lecturer American Society of Nephrology - Board Review Course, 2018-2020
- Distinguished Clinical Service Award American Society of Nephrology, 2019
- Core Faculty and Innovator University of Chicago- Center for Healthcare Delivery Science and Innovation, 2017
- Join now to see all
Clinical Trials
- Continuous Venovenous Hemofiltration Versus Continuous Venovenuous Hemodialysis Start of enrollment: 2009 Jan 01
- The Effect of Loop Diuretics on Severity and Outcome of Acute Kidney Injury Start of enrollment: 2010 Dec 01
- Observational Study of Blood Pressure Measurements and Continuous Dialysis Start of enrollment: 2011 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Sepsis-associated acute kidney injury: recent advances in enrichment strategies, sub-phenotyping and clinical trials.Matthieu Legrand, Sean M Bagshaw, Pavan K Bhatraju, Azra Bihorac, Ellen Caniglia, Ashish K Khanna, John A Kellum, Jay Koyner, Michael O Harhay, Fernando G Zampieri, Al...> ;Critical Care. 2024 Mar 21
- Initial renal replacement therapy (RRT) modality associates with 90-day postdischarge RRT dependence in critically ill AKI survivors.Mackey, R., Echeverri, J., Rosenthal, N., Carabuena, L., Bronson-Lowe, D., Harenski, K., Koyner, J., Neyra, J.> ;Journal of Critical Care. 2024 Mar 8
- Exploring the Cost-Utility of a Biomarker Predicting Persistent Severe Acute Kidney Injury: The Case of C-C Motif Chemokine Ligand 14 (CCL14).Echeverri, J., Martins, R., Harenski, K., Kampf, J., McPherson, P., Textoris, J., Koyner, J.> ;Clinicoeconomics and Outcomes Research. 2024 Jan 1
- Join now to see all
Authored Content
- handbook of critical care nephrologyJune 2021
Press Mentions
AI Predicts Kidney Complications Following HospitalizationNovember 4th, 2022- Glomerular Biomarkers – Peering into the FutureFebruary 10th, 2021
Simple Test Detects Increased Risks in Patients with Acute Kidney InjuryJanuary 30th, 2015
Grant Support
- An Early Real-Time Electronic Health Record Risk Algorithm for the Prevention and Treatment of Acute Kidney Injury: A Randomized Trial of an Early Standardized, Personalized Nephrology InterventionNIH-NIDDK2018–Present
- The Impact of Fluid Balance on Mortality in Patients Requiring Continuous DialysisFresenius Medical2021–2023
- The Role Of Cystatin C In Acute Kidney InjuryNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2012
Professional Memberships
- Member
- Member
- Member
- Member
Other Languages
- Spanish
Hospital Affiliations
University of Chicago Medical CenterChicago, Illinois
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
